Cite
HARVARD Citation
Yu, Y. et al. (2020). Talazoparib Exposure‐Efficacy Analysis in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA Trial. Journal of clinical pharmacology. pp. 1324-1333. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yu, Y. et al. (2020). Talazoparib Exposure‐Efficacy Analysis in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA Trial. Journal of clinical pharmacology. pp. 1324-1333. [Online].